AMERICAN HEALTHCARE REIT INC

Company Overview

American Healthcare REIT, Inc. is a self‑managed Maryland REIT that acquires, owns and operates clinical healthcare real estate, with a portfolio of 313 buildings (~19.09 million sq. ft.) across integrated senior health campuses (126 campuses), outpatient medical buildings, senior housing operating properties (SHOP) and triple‑net leased assets. The company uses RIDEA/TRS structures to capture operating upside on leased-and-operated assets while preserving REIT tax status and targets income through acquisitions, selective development (Trilogy), sale‑leasebacks and real‑estate loans. Recent operating improvement has been driven by higher resident fees, occupancy and targeted acquisitions, but results remain sensitive to operator performance, government reimbursement regimes, labor/inflationary pressures and access to capital markets.

Executive Compensation Practices

Compensation for executives at AHR is likely tied to real‑estate and healthcare‑specific operating metrics—primarily FFO/NAREIT FFO (and normalized FFO), NOI, occupancy and resident revenue growth—reflecting the company’s emphasis on cash flow generation from RIDEA and SHOP operations. Given the REIT structure and the company’s use of an operating partnership (98.7% ownership), long‑term incentives commonly include OP units, equity awards and performance‑based awards that vest on multi‑year FFO/NOI, acquisition or NAV targets, plus time‑vested stock to align with distribution requirements. Management’s recent capital actions (large equity raises, ATM program, debt paydowns) suggest bonuses or LTIP outcomes may also be influenced by leverage reduction, capital‑markets access and successful execution of portfolio optimization and development (Trilogy) goals. Because the company calls out critical accounting estimates and impairment risk, compensation plans may include adjustments or gating provisions tied to impairment/write‑down events or restatements.

Insider Trading Considerations

Insider trading at AHR should be watched around several catalysts: quarterly earnings and FFO/occupancy disclosures, acquisition or disposition announcements, equity offerings/ATM sales and material operator or reimbursement news—each can materially affect short‑term valuation of a healthcare REIT. The company’s heavy use of equity raises in 2024 and an active ATM program creates context for insider sales and potential dilution; executives may be subject to blackout windows, 10b5‑1 plans, and additional restrictions during registered offerings. Because AHR is self‑managed with significant operating‑partnership ownership and a relatively small management headcount, insiders may hold meaningful OP units or equity positions, so large filings (Forms 4/5) can signal management views on valuation or capital needs. Regulatory sensitivities specific to healthcare REITs—Medicare/Medicaid reimbursement, state licensure/CON, and REIT distribution rules—mean insiders will often have material nonpublic information about occupancy, operator performance and reimbursement changes, increasing the importance of strict insider‑trading controls and timely Section 16 reporting.